Abstract:Objective To analysis the modified Gleason scoring system for predicting the prognosis after radical prostatectomy.Methods A total of 242 patients who received radical prostatectomy from April,2006 to October 2011 were recruited.The patients who lost follow-up or had adjuvant radiation or hormonal therapy or had visceral or bone metastasis were excluded,the remaining 168 patients were evaluated in the present study.The patients' age ranged from 53 to 85 years old (mean age 69 years old).The mean PSA level was 13.31ng/ml (ranging from 4.59 to 36.12 ng/ml).According to the traditional Gleason scoring system,there were 50 patients in Gleason ≤ 6 group,86 patients in Gleason 7 group and 32 patients in Gleason≥8 group.Patients were divided in five groups according to the modified Gleason scoring system.There were 50 patients in Gleason ≤6 group,67 in Gleason 3 + 4 group,19 in Gleason 4 + 3 group,15 in Gleason 8 group and 17 in Gleason 9-10 group.The biochemical-free-survival curve was drawn by Kaplan-Meier method and the multivariate Cox regression models were used to evaluate the clinical and pathological variables for the development of biochemical recurrence.ROC curve analysis was used to determine the predicted value for 5-year BCR of modified and traditional Gleason scoring.Results Significant differences were noted between the modified Gleason scoring groups and traditional Gleason scoring groups in PSA value (P =0.005),pathological stage (P =0.002),extraprostatic extension (P =0.003),seminal vesicle invasion (P =0.004),lymph node involvement (P =0.049) and positive surgical margin (P =0.006).With a median follow-up of 68 months(ranging from 7 to 98 months),5-year BFS rates for men with Gleason grade ≤6,3 + 4,4 + 3,8 and 9-10 tumours on RP pathology were 84.0％ (42/50),76.1％ (51/67),57.9％(11/19),40.0％ (9/15),29.4％ (5/17),respectively.On multivariate analysis,the HR value of Gleason 3 + 4 group and Gleason 4 + 3 group were 1.736 and 2.075 (P ＜ 0.05).The area under the curve in modified and traditional Gleason scoring were 0.698 (95％ CI 0.609-0.788) and 0.674 (95％ CI O.584-0.764),respectively.Conclusions The modified Gleason scoring system is related to the prostate cancer grade and its survival rate.Therefore,it can predict prognosis accurately in patients with prostate cancer.It can potential to reduce overtreatment in patients with Gleason 3 +4 prostate cancer.

[Impact of International Association of Urological Pathology Gleason Scoring System on Prostatic Carcinoma Grading: a Preliminary Analysis of 185 Cases].

Basic Features of the ISUP Prostate Carcinoma Gleason Grading System: A Preliminary Analysis

Pathological features, Gleason grading and prognostic grade grouping of prostatic carcinoma: analyses of 119 cases of prostate needle biopsy specimens

[Reproducibility of Gleason Scores in Prostate Cancer].

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?

Exploration on Gleason Score Variation Trend of Patients with Prostate Carcinoma from 1996 to 2019: a Retrospective Single Center Study

Upgrade in Gleason Score Between Biopsy and Radical Prostatectomy Pathology Indicates Poor Outcomes in Prostate Cancer

Prognostic Models for Patients with Gleason Score 9 Prostate Cancer: A Population-Based Study.

Prognostic Performance of the 1973 and 2004 WHO Grading Classification in Upper Tract Urothelial Carcinoma

Trends in Gleason Scores of Chinese Prostate Carcinoma from 1995 to 2014

Evaluation of the accuracy of biopsy Gleason score as predictors of histological grading of prostate cancer specimens

Evaluation of Gleason Grading As Compared to Histological Grading of Radical Prostatectomy Specimens of Prostate Cancer

Prognostic Significance of Modified Gleason Scoring System after Radical Prostatectomy

Does the Gleason Score 7 Upgrading Always Predict Worse Prognosis?

[Concordance Between Three Integrated Scores Based on Prostate Biopsy and Grade-Grouping of Radical Prostatectomy Specimen].

Systematic Biopsy vs. Prostatectomy: Evaluating Correlations and Grading Discrepancies in Prostate Cancer

Distribution features of Gleason score and its relationship with clinical stages in 346 prostate cancer patients]

Validation of the World Health Organization/International Society of Urological Pathology Grading for Chinese Patients with Clear Cell Renal Cell Carcinoma.

Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?

Tertiary Gleason Pattern 5 is An Independent Risk Factor for Prostate Cancer with GS 7: A Retrospective Study from China.

Volume of Gleason pattern 4 stratifies risk of metastasis and death in patients with Gleason score 3+5=8/5+3=8 positive prostate core biopsies